Onglyza and Compazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Onglyza (saxagliptin hydrochloride) and Compazine (prochlorperazine maleate). Common drug interactions include drug effect delayed among females and mental status changes among males.

The phase IV clinical study analyzes what interactions people have when they take Onglyza and Compazine. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Onglyza?

Onglyza has active ingredients of saxagliptin hydrochloride. It is often used in diabetes. eHealthMe is studying from 8,638 Onglyza users. Check the latest studies of Onglyza.

What is Compazine?

Compazine has active ingredients of prochlorperazine maleate. It is often used in nausea and vomiting. eHealthMe is studying from 13,646 Compazine users. Check the latest studies of Compazine.

On Aug, 01, 2026

11 people who take Onglyza and Compazine together, and have interactions are studied.

Onglyza and Compazine drug interactions.

What are the common drug interactions of Onglyza and Compazine, by gender? *:

female:

Drug effect delayed
Hepatic pain (pain in liver)
Limb crushing injury (crushing injury of upper limb)
Mitochondrial myopathy (the muscle fibres do not function due to damage of mitochondria)
Post lumbar puncture syndrome
Road traffic accident
Uterine pain
Abdominal mass (localized enlargement or swelling in the human abdomen)
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Cystitis (inflammation of the wall of the bladder)

male:

Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Pleural effusion (water on the lungs)

What are the common drug interactions of Onglyza and Compazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Bipolar disorder (mood disorder)
Drug effect delayed
Hepatic pain (pain in liver)
Limb crushing injury (crushing injury of upper limb)
Mitochondrial myopathy (the muscle fibres do not function due to damage of mitochondria)
Post lumbar puncture syndrome
Road traffic accident
Uterine pain
Abdominal mass (localized enlargement or swelling in the human abdomen)
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)

50-59:

n/a

60+:

Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Pleural effusion (water on the lungs)
Asthma

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 7 people, 63.64%
Migraine (headache): 4 people, 36.36%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 36.36%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 4 people, 36.36%
Muscle Aches (muscle pain): 4 people, 36.36%
Pain: 3 people, 27.27%
Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain): 3 people, 27.27%
Allergic Rhinitis: 2 people, 18.18%
Burkitt Lymphoma (cancer of the lymphatic system): 2 people, 18.18%
High Blood Pressure: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Onglyza and Compazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously